Medicare Spent $800 Billion Last Year. Is a New Alzheimer’s Drug Worth an Extra $400 Billion?
June 14, 2021 — The Food and Drug Administration’s decision to approve Biogen’s Alzheimer’s drug Aducanumab will accelerate difficult and unavoidable questions for lawmakers and the Centers for Medicare and Medicaid Services (CMS) over Medicare spending and...
Medicare Advantage Topics Investors Should Pay Attention to in 2021
June 24, 2021 — We recently held a policy day exclusively for clients to discuss the outlook for Medicare Advantage. There are eight MA topics we believe investors should pay attention to for 2021–including the Medicare Trust Fund, calculating insurer medical...
Education Department Prioritizes Student Loans Before Gainful Employment, Bundled Services Exemption
June 9, 2021 — In this weekly bulletin, the Capstone Financial Services team shares insights on key policy priorities for the Department of Education (ED) in its administrative capacity. On May 24, ED solicited stakeholder input on various potential regulatory...
The Most Important Infrastructure Number No One is Talking About
May 25, 2021 — On May 13, 2021, the White House released recommendations for the creation of a geospatial Climate and Economic Justice Screening Tool that would help ensure that 40 percent of the benefits of investments in climate and clean infrastructure target...
